Egypt - English - EDA (Egyptian Drug Authority)

eipico-egypt - effervescent tablet - 1 gm

Egypt - English - EDA (Egyptian Drug Authority)

el nile. - effervescent tablet - 1 gm

Bangladesh - English - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - biotin + calcium + chromium + copper + folic acid + iron + magnesium + manganese + niacin + pantothenic acid + riboflavin + selenium + thiamine + vitamin a + vitamin b12 + vitamin b6 + vitamin c + vitamin d + vitamin e + vitamin k + zinc - tablet - 300 mcg + 200 mg + 120 mcg + 2 mg + 400 mcg + 9 mg + 100 mg + 2 mg + 30 mg + 10 mg + 4.2 mg + 20 mcg + 3.75 mg + 2500 iu + 15 mcg + 5 mg + 120 mg + 400 iu + 30 iu + 25 mcg + 15 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

advanced chemical industries limited - biotin + calcium + chromium + copper + folic acid + iron + magnesium + manganese + niacin + pantothenic acid + riboflavin + selenium + thiamine + vitamin a + vitamin b12 + vitamin b6 + vitamin c + vitamin d + vitamin e + vitamin k + zinc - tablet - 300 mcg + 300 mg + 120 mcg + 2 mg + 400 mcg + 18 mg + 50 mg + 2 mg + 30 mg + 10 mg + 2.6 mg + 20 mcg + 2.3 mg + 2500 iu + 9 mcg + 3 mg + 120 mg + 800 iu + 30 iu + 25 mcg + 15 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - carvedilol, quantity: 25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; povidone; crospovidone; colloidal anhydrous silica; magnesium stearate - carvedilol watson is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol watson is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii-iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - carvedilol, quantity: 12.5 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; iron oxide red; iron oxide yellow - carvedilol watson is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol watson is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii-iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - carvedilol, quantity: 6.25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; iron oxide yellow - carvedilol watson is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol watson is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii-iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - carvedilol, quantity: 3.125 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; sucrose; povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; iron oxide red - carvedilol watson is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease. carvedilol watson is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii-iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

revital healthcare (epz) ltd, kenya - sterile single use syringe with re-use prevention features -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

revital healthcare (epz) ltd, kenya - blood administration set -